Literature DB >> 16896965

Preferences among four combination nicotine treatments.

Nina G Schneider1, Margaret A Koury, Chris Cortner, Richard E Olmstead, Neil Hartman, Leonard Kleinman, Andrew Kim, Craig Chaya, David Leaf.   

Abstract

RATIONALE: Acute nicotine replacement treatments (NRTs) are disliked or misused, leading to insufficient nicotine intake and poor outcome. Patches provide steady nicotine but are slow and passive. Combining systems may improve efficacy with acute NRTs tailored for compliance.
OBJECTIVE: To test initial reactions to and use preferences among combinations of NRTs.
MATERIALS AND METHODS: Smokers (n=27) tested four combination NRTs in a 5-day crossover trial: 2/4-mg gum + 15-mg patch (G/P), 2/4-mg lozenges + 15-mg patch (L/P), inhaler + 15-mg patch (I/P), and 10 mg + 15-mg patches (P/P). Subjects rated an NRT combination each day after 5-6 h of use and ranked among the NRTs after testing all treatments.
RESULTS: Double-patches (P/P) were ranked highest for "ease of use", "safety", and "use in public". However, for "help to quit", 70% preferred some form of acute-patch combination (A/P) compared to 30% choosing P/P. For "use under stress" (an immediate need), 93% preferred A/P systems compared to 7% choosing P/P. L/P ranked lowest for "ease of use", I/P and L/P were lowest on "safety", and I/P ranked lowest for "use in public". Expectations of NRTs changed with test experience for patches (better) and lozenges (worse).
CONCLUSIONS: In brief testing, all combinations were acceptable. P/P was favored for ease, safety, and public use, but a majority chose A/P systems for help in quitting and use under stress. Combined use is viable and needs to be made known and accessible to smokers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896965     DOI: 10.1007/s00213-006-0449-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Efficacy of a nicotine lozenge for smoking cessation.

Authors:  Saul Shiffman; Carolyn M Dresler; Peter Hajek; Simon J A Gilburt; Darren A Targett; Kenneth R Strahs
Journal:  Arch Intern Med       Date:  2002-06-10

2.  Pharmacokinetics of a nicotine polacrilex lozenge.

Authors:  Jae H Choi; Carolyn M Dresler; Michele R Norton; Kenneth R Strahs
Journal:  Nicotine Tob Res       Date:  2003-10       Impact factor: 4.244

Review 3.  Nicotine therapy in smoking cessation. Pharmacokinetic considerations.

Authors:  N G Schneider
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 4.  Impact of nicotine replacement therapy on smoking behavior.

Authors:  K Michael Cummings; Andrew Hyland
Journal:  Annu Rev Public Health       Date:  2005       Impact factor: 21.981

5.  Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.

Authors:  M Kornitzer; M Boutsen; M Dramaix; J Thijs; G Gustavsson
Journal:  Prev Med       Date:  1995-01       Impact factor: 4.018

6.  Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.

Authors:  S J Leischow; S N Valente; A L Hill; P S Otte; M Aickin; T Holden; E Kligman; G Cook
Journal:  Exp Clin Psychopharmacol       Date:  1997-02       Impact factor: 3.157

7.  Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler.

Authors:  P Hajek; R West; J Foulds; F Nilsson; S Burrows; A Meadow
Journal:  Arch Intern Med       Date:  1999-09-27

Review 8.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

9.  Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation.

Authors:  N G Schneider; M E Jarvik; A B Forsythe
Journal:  Addict Behav       Date:  1984       Impact factor: 3.913

10.  A comparison of a nicotine sublingual tablet and placebo for smoking cessation.

Authors:  Elbert D Glover; Penny N Glover; Mikael Franzon; C Rollynn Sullivan; Connie C Cerullo; Robert M Howell; Gordon G Keyes; Fredrik Nilsson; Gerald R Hobbs
Journal:  Nicotine Tob Res       Date:  2002-11       Impact factor: 4.244

View more
  7 in total

Review 1.  Smoking cessation and lung cancer: oncology nurses can make a difference.

Authors:  Mary E Cooley; Rebecca L Sipples; Meagan Murphy; Linda Sarna
Journal:  Semin Oncol Nurs       Date:  2008-02       Impact factor: 2.315

2.  A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction.

Authors:  Jessica L Burris; Bryan W Heckman; Amanda R Mathew; Matthew J Carpenter
Journal:  Psychol Addict Behav       Date:  2014-10-27

3.  In vivo Experience With NRT to Increase Adherence and Smoking Abstinence Among Individuals in the Criminal Legal System: Study Protocol for a Randomized Clinical Trial.

Authors:  Elizabeth S Hawes; Sofía Mildrum Chana; Alexandra Faust; Julianne C Baker; Peter S Hendricks; Andres Azuero; Adrienne C Lahti; Matthew J Carpenter; Karen L Cropsey
Journal:  Front Psychiatry       Date:  2022-06-21       Impact factor: 5.435

4.  Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum.

Authors:  Ned L Cooney; Judith L Cooney; Bridget L Perry; Michael Carbone; Emily H Cohen; Howard R Steinberg; David T Pilkey; Kevin Sevarino; Cheryl A Oncken; Mark D Litt
Journal:  Addiction       Date:  2009-06-22       Impact factor: 6.526

Review 5.  Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Authors:  Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

Review 6.  Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems.

Authors:  Lion Shahab; Leonie S Brose; Robert West
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

Review 7.  Practice Quit Attempts: Scoping Review of a Novel Intervention Strategy.

Authors:  Chelsea M Cox; Jennifer C Westrick; Danielle E McCarthy; Matthew J Carpenter; Amanda R Mathew
Journal:  J Stud Alcohol Drugs       Date:  2022-01       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.